Protalix BioTherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	13.65	19.76	23.63	17.11	38.99	18.27
Short-Term Investments	15.72	15.07	20.93	5.07	-	20.28
Cash & Short-Term Investments	29.37	34.83	44.56	22.18	38.99	38.55
Cash Growth	7.16%	-21.84%	100.90%	-43.11%	1.14%	116.64%
Accounts Receivable	14.43	2.91	5.27	4.59	3.44	2
Inventory	21.26	21.24	19.05	16.8	17.95	13.08
Other Current Assets	1.45	1.1	1.06	1.31	1.29	2.1
Total Current Assets	66.5	60.08	69.93	44.88	61.67	55.72
Net Property, Plant & Equipment	12.53	10.02	10.88	9.64	9.92	10.41
Other Long-Term Assets	3.23	3.32	3.62	1.27	2.08	1.8
Total Assets	82.26	73.42	84.43	55.79	73.67	67.93
Accounts Payable	5.38	4.53	4.32	5.86	6.99	7.22
Accrued Expenses	15.17	19.59	19.55	12.27	16.43	13.93
Short-Term Debt	-	-	-	-	-	4.09
Current Portion of Long-Term Debt	-	-	20.25	-	-	54.43
Current Portion of Leases	1.4	1.5	1.41	1.12	1.21	1.42
Unearned Revenue	-	-	-	13.18	8.55	5.39
Total Current Liabilities	21.95	25.62	45.53	32.43	33.18	86.47
Long-Term Debt	-	-	-	28.19	27.89	-
Long-Term Leases	6.78	4.03	4.62	4.17	4.38	4.47
Other Long-Term Liabilities	0.63	0.56	0.71	1.64	14.26	4.03
Total Long-Term Liabilities	7.41	4.59	5.34	34	46.53	8.5
Total Liabilities	29.36	30.21	50.87	66.43	79.7	94.97
Common Stock	-	-	0.07	0.05	0.05	0.04
Additional Paid-in Capital	-	-	415.05	379.17	368.55	320.28
Retained Earnings	-	-	-381.55	-389.86	-374.93	-347.35
Shareholders' Equity	52.91	43.21	33.57	-10.64	-6.04	-27.04
Total Liabilities & Equity	82.26	73.42	84.43	55.79	73.67	67.93
Total Debt	8.18	5.53	26.28	33.47	33.47	64.4
Net Cash (Debt)	21.19	29.3	18.28	-11.29	5.52	-25.86
Net Cash Growth	-27.68%	60.31%	-	-	-	-
Net Cash Per Share	0.25	0.36	0.22	-0.23	0.13	-0.89
Book Value	52.91	43.21	33.57	-10.64	-6.04	-27.04
Book Value Per Share	0.62	0.53	0.41	-0.22	-0.14	-0.93
Tangible Book Value	52.91	43.21	33.57	-10.64	-6.04	-27.04
Tangible Book Value Per Share	0.62	0.53	0.41	-0.22	-0.14	-0.93

Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q